Octapharma AG Hosts Symposium at World Federation of Hemophilia World Congress on "Personalizing the Inhibitor Treatment and Prevention" in Hemophilia A
7/25/2012 10:15:36 AM
LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma AG, a leading producer of human proteins for life saving therapies, proudly sponsored an octanate® symposium “Personalizing the Inhibitor Treatment and Prevention: New Pieces to an Old Puzzle” on July 10th, 2012 at the 30th World Federation of Haemophilia (WFH) Congress in Paris. Over 520 attendees participated in the lunch symposium about inhibitor treatment and prevention in haemophilia A patients. Presented by renowned experts in the field, the symposium was chaired by Manuel Carcao, MD Doctor at the Hospital for Sick Children in Toronto, Canada, and co-chaired by Yves Gruel, Professor at the Trousseau University Hospital in Tours, France.
comments powered by